The preclinical biotech services company provides vivarium operations and services through its network of facilities outside of New York, in Cambridge, MA, Research Triangle Park, NC, and Montreal, Canada – all of which Mispro said are ‘key biotech and life science clusters.’
This new facility 18,000 square foot facility in Broad Hollow Bioscience Park, NY will be the company’s second in the state after it opened a facility in Manhattan in 2010.
Providing vivarium operations, the company supports clients with access to research and animal housing space as well as animal care, regulatory, and compliance services.
Philippe Lamarre, CEO of Mispro Biotech Services, said in a statement that within 25 miles of the facility there are established biopharma organizations and incubators, as well as a growing amount of early-stage biotechs. Farmingdale, New York, home to Broad Hollow Bioscience park is around 40 miles East of Manhattan.
Lamarre told us that with the new facility the company has the opportunity to provide space to the surrounding research community as well as companies headquartered in New York city that need more space or are getting priced out.
“At our very best, we are a catalyst for early-stage companies, enabling them to launch and control their own studies relative to their funding, which we believe will produce increased innovation in therapeutic drug development,” said LaMarre. He added that Mispro is currently seeing ‘tremendous potential’ in its ability to serve the industry.
The company also has plans to expand into Europe in later 2019 and early 2020.
